Keros Therapeutics (KROS) Capital Expenditures Growth (1y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 227.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.57% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 143.40% |
| 10 | Keros Therapeutics | 403.85 Mn | 116.45 Mn | - | -588.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -588.58% |
| Sep 30, 2025 | -9.95% |
| Jun 30, 2025 | -277.40% |
| Mar 31, 2025 | 145.65% |
| Dec 31, 2024 | -46.38% |
| Sep 30, 2024 | 218.66% |
| Jun 30, 2024 | -110.80% |
| Mar 31, 2024 | 995.24% |
| Dec 31, 2023 | -56.11% |
| Sep 30, 2023 | -11,836.36% |
| Jun 30, 2023 | 2,246.03% |
| Mar 31, 2023 | -75.86% |
| Dec 31, 2022 | 672.33% |
| Sep 30, 2022 | -107.59% |
| Jun 30, 2022 | -108.75% |
| Dec 31, 2021 | 165.00% |
| Sep 30, 2021 | 383.33% |
| Jun 30, 2021 | 2,471.43% |
| Dec 31, 2020 | 233.33% |
| Sep 30, 2020 | -63.41% |
| Jun 30, 2020 | -83.63% |